RVP 4.02 Retractable Technologies $RVP Hit a 52 week high of 4.20 Closing the day 09:44 at 4.02 -0.11 -2.66% With a day low of 4.01 and a total volume of 41,107.
RVP Recent Posts: http://investorshangout.com/Retractable-Techn...RVP-57371/
RVP Retractable Technologies Recent Headline News
Update: Retractable Technologies Wins In Syringe Antitrust Suit
Dutch Trader - at Seeking Alpha - Tue Nov 11, 11:32PM CST
BDX: 129.03 (+0.27), RVP: 4.05 (-0.08)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.32 (-0.10), HEAR: 4.06 (+0.09), JRJC: 7.18 (-0.31), CVO: 1.88 (+0.32), AAOI: 12.22 (+0.48), UNIS: 3.01 (+0.06), HIIQ: 8.41 (-0.82), CYAN: 6.00 (-0.06), PTX: 11.04 (-0.31), TRMR: 2.88 (+0.15), PRKR: 1.05 (-0.04), SUMR: 2.74 (+0.11), VSLR: 12.24 (+0.82), RVP: 4.05 (-0.08), ASCMA: 51.50 (+0.14), ICUI: 83.95 (+3.08), CALL: 8.64 (+0.12), DMD: 5.72 (-0.21), AST: 3.98 (+0.36), ASEI: 45.15 (-1.86)
District Court Issues Order Denying Becton, Dickinson and Company's Renewed Motion for Judgment as a Matter of Law Against Retractable Technologies, Inc.
Business Wire - Mon Oct 06, 10:58AM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP), ("RTI"
announced today that Judge Leonard Davis of the United States District Court for the Eastern District of Texas issued an order on September 30, 2014 denying Becton, Dickinson and Company's ("BD" Renewed Motion for Judgment as a Matter of Law, or Alternatively, for New Trial or Remittitur, ruling that there was sufficient evidence for the jury to: find that BD had attempted to monopolize the safety syringe market, find that BD had engaged in false advertising under the Lanham Act, and award Retractable $113,508,014 in antitrust damages. Pursuant to federal statute, antitrust damages are subject to being trebled.
RVP: 4.05 (-0.08)
Global Safety Syringes Market 2014-2019: Retractable, Automatic Retractable, Manual Retractable & Non Retractable Safety Syringes Analysis
M2 - Wed Sep 17, 3:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b9n3wl/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013-2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. The report on safety syringes market provides comprehensive information about the various facets of the market from detailed product analysis, market trends and future opportunities to the competitive landscape. The two major segments described in the study are retractable safety syringes and non-retractable safety syringes. Retractable safety syringes have been further categorized as the automatic retractable safety syringes and manual retractable safety syringes. Non-retractable safety syringes account for all those syringes without retractable mechanism such as sheathing tube syringes, syringes with sliding needle covers and hinged needle covers. Each of these product types and sub-types has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2011 and 2012 as the base years. The report concludes with the company profiles of the key players operating in this market. Becton, Dickinson & Company, Covidien plc, Retractable Technologies, Inc., Revolutions Medical Corporation, Smiths Medical, Terumo Corporation and Unilife Corporation are the major players profiled in this report. The global safety syringes market is segmented as follows: Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Key Topics Covered: - Preface - Executive Summary - Market Overview - Global Safety Syringes Market, by Product Type - Global Safety Syringes Market Revenue, by Geography - Recommendations - Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/b9...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Safety Syringes Market - Global Industry Analysis Forecasts to 2019
M2 - Thu Aug 28, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rsq89/safety_syringes) has announced the addition of the "Safety Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019 Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/2r...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Reports Results of Operations
Business Wire - Thu Aug 14, 3:38PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and six months ended June 30, 2014 and 2013, respectively.
RVP: 4.05 (-0.08)
Global Safety Syringes Market 2013-2019: Retractable, Automatic Retractable, Manual Retractable Non-Retractable Safety Syringes
M2 - Tue Jul 22, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d73f6p/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Safety Syringes Market, by Product Type Chapter 5 Global Safety Syringes Market Revenue, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/d7...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders
Business Wire - Wed Jun 25, 3:44PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from March 31, 2014 through date of conversion or June 30, 2014, whichever is applicable. The dividends will be paid on July 21, 2014 to shareholders of record as of the close of business on July 10, 2014.
RVP: 4.05 (-0.08)
Global Hypodermic Needles Market 2014-2018 with Becton, Dickinson and Co, Covidien, Retractable Technologies, Terumo Dominating
M2 - Wed Jun 25, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7dbr2/global_hypodermic) has announced the addition of the "Global Hypodermic Needles Market 2014-2018" report to their offering. The Global Hypodermic Needles market will grow at a CAGR of 6.66 percent over the period 2013-2018. The Global Hypodermic Needles market is driven by several factors, of which the introduction and enforcement of legislations in various countries for the mandatory use of safety needles is one of the major drivers. Governments worldwide have begun implementing legislation that limits the frequency of actions that often lead to a NSI. With the introduction and enforcement of such legislation, Healthcare and Pharmaceutical markets across the world are now transitioning to the mandatory use of safety needles/syringes to help protect those at risk of infection from NSIs and other unsafe injection practices. These compulsory regulations will have a huge impact and will increase the Global Hypodermic Needles market. According to various legislations, HCWs are required to implement formal written exposure control plans and actively involve frontline HCWs in the selection of safe needle devices. Legislation also requires HCWs to create and maintain sharps injury log books, or to save electronically, which contain detailed information on the type, brand, and manufacturer of devices associated with such injuries. Further, the report states that one of the major challenges faced by the market is the difficulty in the adoption of safety mechanisms by HCWs. The revenue generated in this market can be segmented based on the following types of needle - Manual - Semi-automatic - Automatic/Passive Key Vendors - Becton, Dickinson and Co. - Covidien Ltd. - Retractable Technologies Inc. - Terumo Corp. Other Prominent Vendors - Albert David Ltd. - B-Braun Melsungen AG - Catalent Pharma Solutions - Connectinut Hypodermics Inc. - C.R. Bard - Exel International - Hamilton Syringes & Needles - Hindustan Syringes & Medical Devices Ltd. - Hi-Tech Syringes - MedPro Safety Products - MW Industries Inc. - Needletech Products Inc. - Revolutions Medical Corp. - Safety Medical Supply Intl. - Simply Surgicals LLC - Smiths Medical - Unilife Corp. - Vigmed AB - Vita Needle Co. - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation By Type - Product Portfolio - Global Non-Safety Needles Market - Global Safety Needles Market - Geographical Segmentation - Key Leading Countries in the Global Hypodermic Needles market - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/c7...hypodermic
UNIS: 3.01 (+0.06), COV: 92.93 (-0.78), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Announces Verdict
Business Wire - Thu Sep 19, 9:28PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP), a leading maker of safety medical devices, announced today that a Tyler, Texas jury returned a verdict in the litigation of Retractable Technologies, Inc. v. Becton, Dickinson and Company in favor of Retractable. After a six year battle, the verdict vindicates Retractable's claim that industry giant Becton, Dickinson and Company illegally engaged in anticompetitive conduct with the intent to acquire or maintain monopoly power in the safety syringe market and engaged in false advertising under the Lanham Act. The jury awarded Retractable $113,508,014 in compensatory damages subject to being trebled pursuant to federal statute. Retractable is represented by Locke Lord LLP; Ireland, Carroll & Kelley, P.C.; and Jim Parsons Law.
RVP: 4.05 (-0.08)
Retractable Technologies Inc's board reports dividends on preferred stock
M2 - Thu Jun 27, 5:50AM CDT
The board of directors of Retractable Technologies Inc (NYSE MKT:RVP), a provider of safety medical products, declared on Wednesday its dividends of USD12,937.50 and USD44,675.00 to its preferred stock shareholders.
RVP: 4.05 (-0.08)
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
ABT: 44.13 (-0.12), BDX: 129.03 (+0.27), NVO: 44.17 (-0.16), BAX: 71.21 (+0.45), COV: 92.93 (-0.78), RVP: 4.05 (-0.08), MMSI: 15.44 (+0.19)
AllPennyStocks.com News: Two Small-Cap Stocks Head and Shoulders Above Peers with New Drug Delivery Systems
ACCESSWIRE-TNW - Tue Feb 12, 4:00PM CST
MISSISSAUGA, Ontario, February 12, 2013 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Two Small-Cap Stocks Head and Shoulders Above Peers with New Drug Delivery Systems."
BIIB: 320.98 (-3.61), UNIS: 3.01 (+0.06), LLY: 67.63 (-0.22), RVP: 4.05 (-0.08), SNY: 46.30 (-0.84), ATRS: 2.33 (+0.03)
U.S. Market for Vascular Access Devices and Accessories (Executive Summary)
M2 - Thu Feb 07, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/x85mjb/u_s_market_for) has announced the addition of the "U.S. Market for Vascular Access Devices and Accessories (Executive Summary)" report to their offering. In 2012, the U.S. market for vascular access devices and accessories was nearly $4 billion, a 6.1% increase over the previous year. The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019. Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. C
SI: 132.66 (-1.58), EW: 122.68 (-2.11), RVP: 4.05 (-0.08)
Research Report on the $4 billion U.S. Market for Vascular Access Devices and Accessories
M2 - Wed Feb 06, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/gbs34x/u_s_market_for) has announced the addition of the "U.S. Market for Vascular Access Devices and Accessories" report to their offering. In 2012, the U.S. market for vascular access devices and accessories was nearly $4 billion, a 6.1% increase over the previous year. The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019. Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. Report Contents: - Co
SI: 132.66 (-1.58), EW: 122.68 (-2.11), RVP: 4.05 (-0.08)
RVP Recent Posts: http://investorshangout.com/Retractable-Techn...RVP-57371/
RVP Retractable Technologies Recent Headline News
Update: Retractable Technologies Wins In Syringe Antitrust Suit
Dutch Trader - at Seeking Alpha - Tue Nov 11, 11:32PM CST
BDX: 129.03 (+0.27), RVP: 4.05 (-0.08)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.32 (-0.10), HEAR: 4.06 (+0.09), JRJC: 7.18 (-0.31), CVO: 1.88 (+0.32), AAOI: 12.22 (+0.48), UNIS: 3.01 (+0.06), HIIQ: 8.41 (-0.82), CYAN: 6.00 (-0.06), PTX: 11.04 (-0.31), TRMR: 2.88 (+0.15), PRKR: 1.05 (-0.04), SUMR: 2.74 (+0.11), VSLR: 12.24 (+0.82), RVP: 4.05 (-0.08), ASCMA: 51.50 (+0.14), ICUI: 83.95 (+3.08), CALL: 8.64 (+0.12), DMD: 5.72 (-0.21), AST: 3.98 (+0.36), ASEI: 45.15 (-1.86)
District Court Issues Order Denying Becton, Dickinson and Company's Renewed Motion for Judgment as a Matter of Law Against Retractable Technologies, Inc.
Business Wire - Mon Oct 06, 10:58AM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP), ("RTI"
announced today that Judge Leonard Davis of the United States District Court for the Eastern District of Texas issued an order on September 30, 2014 denying Becton, Dickinson and Company's ("BD" Renewed Motion for Judgment as a Matter of Law, or Alternatively, for New Trial or Remittitur, ruling that there was sufficient evidence for the jury to: find that BD had attempted to monopolize the safety syringe market, find that BD had engaged in false advertising under the Lanham Act, and award Retractable $113,508,014 in antitrust damages. Pursuant to federal statute, antitrust damages are subject to being trebled. RVP: 4.05 (-0.08)
Global Safety Syringes Market 2014-2019: Retractable, Automatic Retractable, Manual Retractable & Non Retractable Safety Syringes Analysis
M2 - Wed Sep 17, 3:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b9n3wl/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013-2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. The report on safety syringes market provides comprehensive information about the various facets of the market from detailed product analysis, market trends and future opportunities to the competitive landscape. The two major segments described in the study are retractable safety syringes and non-retractable safety syringes. Retractable safety syringes have been further categorized as the automatic retractable safety syringes and manual retractable safety syringes. Non-retractable safety syringes account for all those syringes without retractable mechanism such as sheathing tube syringes, syringes with sliding needle covers and hinged needle covers. Each of these product types and sub-types has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2011 and 2012 as the base years. The report concludes with the company profiles of the key players operating in this market. Becton, Dickinson & Company, Covidien plc, Retractable Technologies, Inc., Revolutions Medical Corporation, Smiths Medical, Terumo Corporation and Unilife Corporation are the major players profiled in this report. The global safety syringes market is segmented as follows: Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Key Topics Covered: - Preface - Executive Summary - Market Overview - Global Safety Syringes Market, by Product Type - Global Safety Syringes Market Revenue, by Geography - Recommendations - Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/b9...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Safety Syringes Market - Global Industry Analysis Forecasts to 2019
M2 - Thu Aug 28, 5:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2rsq89/safety_syringes) has announced the addition of the "Safety Syringes Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019 Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Safety Syringes Market, by Product Type - Retractable Safety Syringes - Automatic Retractable Safety Syringes - Manual Retractable Safety Syringes - Non Retractable Safety Syringes Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/2r...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Reports Results of Operations
Business Wire - Thu Aug 14, 3:38PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the three and six months ended June 30, 2014 and 2013, respectively.
RVP: 4.05 (-0.08)
Global Safety Syringes Market 2013-2019: Retractable, Automatic Retractable, Manual Retractable Non-Retractable Safety Syringes
M2 - Tue Jul 22, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d73f6p/safety_syringes) has announced the addition of the "Safety Syringes - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013" report to their offering. The global market for safety syringes was valued at USD 3,419.1 million in 2012 and is expected to reach USD 6,496.8 million by the end of 2019, growing at a CAGR of 9.7% during the forecast period from 2013 to 2019. Two major types of safety syringes available in the market consist of retractable safety syringes and non-retractable-safety syringes. In 2012, non-retractable safety syringes that include sheathing tube syringes, syringes with sliding needle covers and hinged needle covers accounted for the larger share in terms of revenue (USD Million) as well as volume (Million Units). However, during the forecast period, the market for retractable safety syringes is expected to grow at a higher CAGR than the non-retractable safety syringes due to increasing safety concerns and adoption in developed regions. The market for retractable safety syringes has been further segmented as automatic retractable safety syringes and manual retractable safety syringes. Automatic retractable safety syringes are more preferred than manual retractable syringes owing to advantage such as ease of use and enhanced safety. The global market for safety syringes is primarily driven by factors such as increasing cases of needlestick injuries and their serious consequences, governmental legislation, overall growth in injectable drugs market and technical advances leading to syringes with improved safety features. According to the U.S. Occupational Safety and Health Administration (OSHA), approximately 5.6 million healthcare workers across the U.S. are high risk of exposure to blood borne diseases via needlestick and other sharp related injuries. The above mentioned fact indicates a favorable growth for safety syringes market. However, the market may face significant challenges from higher cost associated with the safety syringes and continuous development in alternative drug delivery methods. Safety syringes cost two to three times more than the traditional syringes that results in slow adoption rate of safety syringes across the healthcare facilities. This factor is more prominent across the developing nations where healthcare providers believe that the incidence of needlestick injuries can be prevented by providing training to healthcare workers and thus, avoids spending money on purchasing safety syringes. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Safety Syringes Market, by Product Type Chapter 5 Global Safety Syringes Market Revenue, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Becton, Dickinson & Company - Covidien plc - Retractable Technologies, Inc. - Revolutions Medical Corporation - Smiths Medical - Terumo Corporation - Unilife Corporation For more information visit http://www.researchandmarkets.com/research/d7...y_syringes
BDX: 129.03 (+0.27), UNIS: 3.01 (+0.06), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock Shareholders
Business Wire - Wed Jun 25, 3:44PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,937.50 and $44,675.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders. Dividends have accrued at 10% per annum and cover amounts in arrears from March 31, 2014 through date of conversion or June 30, 2014, whichever is applicable. The dividends will be paid on July 21, 2014 to shareholders of record as of the close of business on July 10, 2014.
RVP: 4.05 (-0.08)
Global Hypodermic Needles Market 2014-2018 with Becton, Dickinson and Co, Covidien, Retractable Technologies, Terumo Dominating
M2 - Wed Jun 25, 8:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7dbr2/global_hypodermic) has announced the addition of the "Global Hypodermic Needles Market 2014-2018" report to their offering. The Global Hypodermic Needles market will grow at a CAGR of 6.66 percent over the period 2013-2018. The Global Hypodermic Needles market is driven by several factors, of which the introduction and enforcement of legislations in various countries for the mandatory use of safety needles is one of the major drivers. Governments worldwide have begun implementing legislation that limits the frequency of actions that often lead to a NSI. With the introduction and enforcement of such legislation, Healthcare and Pharmaceutical markets across the world are now transitioning to the mandatory use of safety needles/syringes to help protect those at risk of infection from NSIs and other unsafe injection practices. These compulsory regulations will have a huge impact and will increase the Global Hypodermic Needles market. According to various legislations, HCWs are required to implement formal written exposure control plans and actively involve frontline HCWs in the selection of safe needle devices. Legislation also requires HCWs to create and maintain sharps injury log books, or to save electronically, which contain detailed information on the type, brand, and manufacturer of devices associated with such injuries. Further, the report states that one of the major challenges faced by the market is the difficulty in the adoption of safety mechanisms by HCWs. The revenue generated in this market can be segmented based on the following types of needle - Manual - Semi-automatic - Automatic/Passive Key Vendors - Becton, Dickinson and Co. - Covidien Ltd. - Retractable Technologies Inc. - Terumo Corp. Other Prominent Vendors - Albert David Ltd. - B-Braun Melsungen AG - Catalent Pharma Solutions - Connectinut Hypodermics Inc. - C.R. Bard - Exel International - Hamilton Syringes & Needles - Hindustan Syringes & Medical Devices Ltd. - Hi-Tech Syringes - MedPro Safety Products - MW Industries Inc. - Needletech Products Inc. - Revolutions Medical Corp. - Safety Medical Supply Intl. - Simply Surgicals LLC - Smiths Medical - Unilife Corp. - Vigmed AB - Vita Needle Co. - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation By Type - Product Portfolio - Global Non-Safety Needles Market - Global Safety Needles Market - Geographical Segmentation - Key Leading Countries in the Global Hypodermic Needles market - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/c7...hypodermic
UNIS: 3.01 (+0.06), COV: 92.93 (-0.78), RVP: 4.05 (-0.08)
Retractable Technologies, Inc. Announces Verdict
Business Wire - Thu Sep 19, 9:28PM CDT
Retractable Technologies, Inc. (NYSE MKT: RVP), a leading maker of safety medical devices, announced today that a Tyler, Texas jury returned a verdict in the litigation of Retractable Technologies, Inc. v. Becton, Dickinson and Company in favor of Retractable. After a six year battle, the verdict vindicates Retractable's claim that industry giant Becton, Dickinson and Company illegally engaged in anticompetitive conduct with the intent to acquire or maintain monopoly power in the safety syringe market and engaged in false advertising under the Lanham Act. The jury awarded Retractable $113,508,014 in compensatory damages subject to being trebled pursuant to federal statute. Retractable is represented by Locke Lord LLP; Ireland, Carroll & Kelley, P.C.; and Jim Parsons Law.
RVP: 4.05 (-0.08)
Retractable Technologies Inc's board reports dividends on preferred stock
M2 - Thu Jun 27, 5:50AM CDT
The board of directors of Retractable Technologies Inc (NYSE MKT:RVP), a provider of safety medical products, declared on Wednesday its dividends of USD12,937.50 and USD44,675.00 to its preferred stock shareholders.
RVP: 4.05 (-0.08)
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
ABT: 44.13 (-0.12), BDX: 129.03 (+0.27), NVO: 44.17 (-0.16), BAX: 71.21 (+0.45), COV: 92.93 (-0.78), RVP: 4.05 (-0.08), MMSI: 15.44 (+0.19)
AllPennyStocks.com News: Two Small-Cap Stocks Head and Shoulders Above Peers with New Drug Delivery Systems
ACCESSWIRE-TNW - Tue Feb 12, 4:00PM CST
MISSISSAUGA, Ontario, February 12, 2013 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Two Small-Cap Stocks Head and Shoulders Above Peers with New Drug Delivery Systems."
BIIB: 320.98 (-3.61), UNIS: 3.01 (+0.06), LLY: 67.63 (-0.22), RVP: 4.05 (-0.08), SNY: 46.30 (-0.84), ATRS: 2.33 (+0.03)
U.S. Market for Vascular Access Devices and Accessories (Executive Summary)
M2 - Thu Feb 07, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/x85mjb/u_s_market_for) has announced the addition of the "U.S. Market for Vascular Access Devices and Accessories (Executive Summary)" report to their offering. In 2012, the U.S. market for vascular access devices and accessories was nearly $4 billion, a 6.1% increase over the previous year. The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019. Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. C
SI: 132.66 (-1.58), EW: 122.68 (-2.11), RVP: 4.05 (-0.08)
Research Report on the $4 billion U.S. Market for Vascular Access Devices and Accessories
M2 - Wed Feb 06, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/gbs34x/u_s_market_for) has announced the addition of the "U.S. Market for Vascular Access Devices and Accessories" report to their offering. In 2012, the U.S. market for vascular access devices and accessories was nearly $4 billion, a 6.1% increase over the previous year. The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019. Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S. Report Contents: - Co
SI: 132.66 (-1.58), EW: 122.68 (-2.11), RVP: 4.05 (-0.08)
